General
Preferred name
TYRPHOSTIN A9
Synonyms
AG 17 ()
SF 6847 ()
RG-50872 ()
Malonoben ()
Tyrphostin 9 ()
AG-17 ()
SF 6847, RG-50872 ()
P&D ID
PD002632
CAS
10537-47-0
Tags
natural product
available
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Selective PDGF tyrosine kinase receptor inhibitor (LOPAC library)
DESCRIPTION Tyrphostin 9 is firstly designed as an EGFR inhibitor with IC50 of 460 μM, but is also found to be more potent to PDGFR with IC50 of 0.5 μM. (BOC Sciences Bioactive Compounds)
Cell lines
1
Organisms
3
Compound Sets
10
AdooQ Bioactive Compound Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugMatrix
EU-OPENSCREEN Bioactive Compound Library
LOPAC library
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
27
Properties
(calculated by RDKit )
Molecular Weight
282.17
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
1
Ring Count
1
Aromatic Ring Count
1
cLogP
4.42
TPSA
67.81
Fraction CSP3
0.44
Chiral centers
0.0
Largest ring
6.0
QED
0.78
QED
0.78
Structural alerts
1
ene_cyano_A(19)
[#6](-[#6]#[#7])(-[#6]#[#7])=[#6]-c:1:c:c:c:c:c:1
PAINS Family B
Custom attributes
(extracted from source data)
Selectivity
PDGFR
Pathway
Angiogenesis
JAK/STAT Signaling
Tyrosine Kinase/Adaptors
Chromatin/Epigenetic
Anti-infection
Protein Tyrosine Kinase/RTK
Target
EGFR
Influenza Virus
VEGFR
EGFR,PDGFR
MOA
protein tyrosine kinase inhibitor, tyrosine kinase inhibitor
Solubility
In Vitro:<br/>DMSO : ≥ 100 mg/mL (354.13 mM)<br/>H2O : < 0.1 mg/mL (insoluble)
Source data